FDA
# EUA Revocations
`Revocation 'Pre-Omicron'`

- Bamlanivimab monotherapy (w/o concomitant etesevimab)

!!! Warning `Revocation in Nationwide Omicron Domianance`
    - Bamlanivimab
    - Etesevimab 
    - Casirivimab
    - Imdevimab

# EUA Active
!!!  Treatment, High Risk of Progression post-seroconversion:
    - Sotrovimab
    - Bebtelovimab

!!! PrEP, certain Immunocompromised High Risk population:
    - Tixagavimab
    - Cilgavimab
